What are SGLT-2 Inhibitors? The sodium-glucose cotransporter-2 proteins in the kidneys are the target of a class of oral diabetic medications known as SGLT-2 inhibitors. Diabetes is associated with high blood glucose levels because of these transporters' normal ability to reabsorb glucose from the urine back into the circulation. SGLT-2 inhibitors facilitate the excretion of excess glucose...